-+ 0.00%
-+ 0.00%
-+ 0.00%

COSMOS HEALTH REPORTS ANNUALIZED SALES EXCEEDING $1.5M FOR ITS C-SCRUB AND C-SEPT ANTISEPTIC BRANDS IN THE UK AND GREECE; PLANS EU EXPANSION TARGETING $7.4M IN REVENUE AND $5.3M IN GROSS PROFIT

Reuters·06/12/2026 13:29:00

Please log in to view news